Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis

IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy

(2019) Marc Humbert et al.   Journal of Allergy and Clinical Immunology-In Practice

EUFOREA Consensus on Biologics for CRS w NP with or without asthma

(2019) W J Fokkens et al.   ALLERGY

Treatable traits in chronic rhinosinusitis with nasal polyps

(2019) Enrico Heffler et al.   Current Opinion in Allergy and Clinical Immunology

New Targeted Therapies for Uncontrolled Asthma

(2019) Jonathan Corren   Journal of Allergy and Clinical Immunology-In Practice

Cross-talk between TH2 and TH17 pathways in patients with chronic rhinosinusitis with nasal polyps

(2019) Min Wang et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Association between exhaled nitric oxide and nasal polyposis in severe asthma

(2019) Mauro Maniscalco et al.   RESPIRATORY MEDICINE

Asthma from immune pathogenesis to precision medicine

(2019) Kareem Khalaf et al.   SEMINARS IN IMMUNOLOGY

Effectiveness of Omalizumab in Severe Allergic Asthma and Nasal Polyposis: A Real-Life Study

(2019) A Tiotiu et al.   JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY

Diagnostic Accuracy of Urinary LTE4 Measurement to Predict Aspirin-Exacerbated Respiratory Disease in Patients with Asthma

(2018) Grazyna Bochenek et al.   Journal of Allergy and Clinical Immunology-In Practice

Diagnosis and Management of NSAID-Exacerbated Respiratory Disease (N-ERD) - a EAACI position paper

(2018) Marek L. Kowalski et al.   ALLERGY

Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease

(2018) Merin E. Kuruvilla et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps

(2018) Enrico Heffler et al.   Expert Review of Clinical Immunology

The Severe Asthma Network in Italy: Findings and Perspectives

(2018) Enrico Heffler et al.   Journal of Allergy and Clinical Immunology-In Practice

Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study

(2018) Giorgio Walter Canonica et al.   World Allergy Organization Journal

Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study

(2018) Corrado Pelaia et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Co-morbidities in severe asthma: Clinical impact and management

(2017) Celeste Porsbjerg et al.   RESPIROLOGY

Differential effect of omalizumab on pulmonary function in patients with allergic asthma with and without chronic rhinosinusitis

(2016) Matthew J. Clavenna et al.   ALLERGY AND ASTHMA PROCEEDINGS

Treatable traits: toward precision medicine of chronic airway diseases

(2016) Alvar Agusti et al.   EUROPEAN RESPIRATORY JOURNAL

Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort

(2015) Dominick E. Shaw et al.   EUROPEAN RESPIRATORY JOURNAL

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

(2013) K. F. Chung et al.   EUROPEAN RESPIRATORY JOURNAL

Nasal nitric oxide is a marker of poor asthma control

(2013) Enrico Heffler et al.   Journal of Breath Research

Asthma outcomes: Pulmonary physiology

(2012) Robert S. Tepper et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

(2011) William W. Busse et al.   NEW ENGLAND JOURNAL OF MEDICINE

Determinants of Exhaled Nitric Oxide in Chronic Rhinosinusitis

(2009) Giuseppe Guida et al.   CHEST

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

(2008) Erik von Elm et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY